The estimated Net Worth of William G Gerber is at least $407 millier dollars as of 6 December 2007. William Gerber owns over 6,100 units of Sangamo Therapeutics Inc stock worth over $57,372 and over the last 20 years William sold SGMO stock worth over $349,450.
William has made over 6 trades of the Sangamo Therapeutics Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently William sold 6,100 units of SGMO stock worth $97,600 on 6 December 2007.
The largest trade William's ever made was selling 6,100 units of Sangamo Therapeutics Inc stock on 6 December 2007 worth over $97,600. On average, William trades about 2,392 units every 13 days since 2004. As of 6 December 2007 William still owns at least 68,300 units of Sangamo Therapeutics Inc stock.
You can see the complete history of William Gerber stock trades at the bottom of the page.
William's mailing address filed with the SEC is 21720 23RD DRIVE SE, SUITE 150, BOTHELL, WA, 98021.
Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp et Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.
for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: